Buprenorphine and naloxone for heroin dependence

RE Johnson, JC McCagh - Current psychiatry reports, 2000 - Springer
The pharmacology of buprenorphine is unique because of its partial agonist profile at the mu-
opioid receptor (ie, high affinity, low intrinsic activity and slow dissociation). This unique …

Buprenorphine and Naloxone for Heroin Dependence

RE Johnson, JC McCagh - Current Psychiatry Reports, 1996 - infona.pl
The pharmacology of buprenorphine is unique because of its partial agonist profile at the mu-
opioid receptor (ie, high affinity, low intrinsic activity and slow dissociation). This unique …

Buprenorphine and naloxone for heroin dependence

RE Johnson, JC McCagh - Current psychiatry reports, 2000 - pubmed.ncbi.nlm.nih.gov
The pharmacology of buprenorphine is unique because of its partial agonist profile at the mu-
opioid receptor (ie, high affinity, low intrinsic activity and slow dissociation). This unique …

Buprenorphine and Naloxone for Heroin Dependence

RE Johnson, JC McCagh - Current Psychiatry Reports, 2000 - search.proquest.com
The pharmacology of buprenorphine is unique because of its partial agonist profile at the mu-
opioid receptor (ie, high affinity, low intrinsic activity and slow dissociation). This unique …

Buprenorphine and naloxone for heroin dependence.

RE Johnson, JC McCagh - Current psychiatry reports, 2000 - pure.johnshopkins.edu
The pharmacology of buprenorphine is unique because of its partial agonist profile at the mu-
opioid receptor (ie, high affinity, low intrinsic activity and slow dissociation). This unique …

Buprenorphine and naloxone for heroin dependence.

RE Johnson, JC McCagh - Current Psychiatry Reports, 2000 - europepmc.org
The pharmacology of buprenorphine is unique because of its partial agonist profile at the mu-
opioid receptor (ie, high affinity, low intrinsic activity and slow dissociation). This unique …

[引用][C] Buprenorphine and Naloxone for Heroin Dependence

RE Johnson, JC McCagh - Current Psychiatry Reports, 2000 - Springer